Amod Amritphale is a Cardiology physician affiliated with University of South Alabama. OpenAlex indexes 45 publications with 338 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1235 E Cherokee St
Springfield, MO 658042203
Telephone
417-820-3911Provider last certified this registry record 18 Jul 2022.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shockwave Medical, IncProgram year202512 payments$10,690openpaymentsdata.cms.gov ↗
- BIOTRONIK INC.Program year20253 payments
- Teleflex LLCProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.8%Beta blocker23.5%Metoprolol Succinate62%Metoprolol Tartrate21%Carvedilol18%Part D≥184 patientsStatin20.1%Atorvastatin Calcium67%Rosuvastatin Calcium29%Pravastatin Sodium4%Part D<11 patients+ 14 more classes in this area
Blood & clotting
22.2%P2Y12 inhibitor13.1%Clopidogrel61%Brilinta39%Part D≥90 patientsFactor Xa inhibitor7.8%Eliquis100%Part D≥62 patients+ 2 more classes in this area
Metabolism & gastrointestinal
4.9%SGLT2 inhibitor3.5%Jardiance100%Part D≥31 patientsPotassium supplement0.7%Potassium Chloride100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Predictors of Cardiac Arrest among COVID-19 Patients with Heart Failure
Cardiology and Cardiovascular Medicine
2024 - F-10 | Predictors of Adverse Events Following Endovascular Revascularization of Acute Limb Ischemia: Outcomes of the National Cardiovascular Data Registry Peripheral Vascular Intervention Registry
Journal of the Society for Cardiovascular Angiography & Interventions
2024 - Hospital Readmission Rates in Patients With Neuromyelitis Optica Spectrum Disorder
International Journal of MS Care
2023 - Clinical Predictors of Cardiac Arrest among COVID 19 Patients with Heart Failure
Current Trends in Internal Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Nasser Lakkis, MD
University of South Alabama
Karen Fagan, MD
University of South Alabama
Errol Crook, MD
University of South Alabama
William Broughton, MD
University of South Alabama
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”